Guangzhou Kingmed Diagnostics Group Co Ltd Tangible Net Worth Ratio

Latest as of March 2026: 97.3%

Guangzhou Kingmed Diagnostics Group Co Ltd tangible net worth ratio. Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a Tangible Net Worth Ratio of 97.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥178.15 Million) from net assets (CN¥6.48 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Guangzhou Kingmed Diagnostics Group Co L (603882) strategic asset index to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

97.3%
Tangible equity / total equity

Net Assets (Equity)

CN¥6.48 Billion
CNY

Intangible Assets

CN¥178.15 Million
Goodwill, patents, brand value

Total Assets

CN¥9.20 Billion
CNY

Tangible Net Worth Ratio of Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2025)

Tangible net worth ratio of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2025. This chart shows how Guangzhou Kingmed Diagnostics Group Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 97.3%, reflecting net assets of CN¥6.48 Billion with intangible assets of CN¥178.15 Million CNY. See Guangzhou Kingmed Diagnostics Group Co L (603882) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Guangzhou Kingmed Diagnostics Group Co Ltd Tangible Net Worth Ratio by Year (2012–2025)

Guangzhou Kingmed Diagnostics Group Co Ltd tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Guangzhou Kingmed Diagnostics Group Co L (603882) market capitalisation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 97.4% CN¥6.86 Billion CN¥181.58 Million CN¥9.60 Billion ▼ -0.4 pp
2024 97.7% CN¥7.48 Billion CN¥170.89 Million CN¥10.39 Billion ▼ -0.5 pp
2023 98.2% CN¥8.55 Billion CN¥150.33 Million CN¥11.77 Billion ▼ 0.0 pp
2022 98.3% CN¥8.87 Billion CN¥152.00 Million CN¥13.89 Billion ▼ -0.7 pp
2021 99.0% CN¥6.52 Billion CN¥68.41 Million CN¥10.75 Billion ▲ +2.5 pp
2020 96.4% CN¥3.88 Billion CN¥138.63 Million CN¥6.64 Billion ▼ -0.1 pp
2019 96.6% CN¥2.33 Billion CN¥79.85 Million CN¥4.40 Billion ▲ +1.5 pp
2018 95.1% CN¥1.96 Billion CN¥96.00 Million CN¥3.96 Billion ▲ +0.1 pp
2017 95.0% CN¥1.74 Billion CN¥87.58 Million CN¥3.32 Billion ▼ 0.0 pp
2016 95.0% CN¥1.13 Billion CN¥56.40 Million CN¥2.67 Billion ▼ -4.7 pp
2015 99.7% CN¥959.84 Million CN¥2.69 Million CN¥2.00 Billion ▲ +0.2 pp
2014 99.5% CN¥391.72 Million CN¥1.99 Million CN¥1.39 Billion ▲ +0.5 pp
2013 98.9% CN¥258.41 Million CN¥2.73 Million CN¥860.64 Million ▲ +0.7 pp
2012 98.3% CN¥203.69 Million CN¥3.50 Million CN¥628.95 Million —
pp = percentage points